Jonathan Ramalho
Cardiovascular Disease · East Syracuse, NYNPI 1821452780
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $18,342 of the $28,001 with a category attached, or 65.5%. 19 manufacturers reported payments, led by Biotronik Inc. at 55.2% of the total. Among cardiovascular disease clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 219 payments — averaging $127.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik Inc.$15K
- Medtronic$7K
- Baylis Medical Company Inc$2K
- Medical Device Business Services, Inc.$1K
- Boston Scientific$618
- Abbott$309
- plus $1K from 13 others
What the payments were for
- Travel & lodging$18,34266%
- Food & beverage$8,42630%
- Education$1,2334%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotronik Inc. | 83 | $15,459 |
| Medtronic | 71 | $7,306 |
| Baylis Medical Company Inc | 15 | $1,884 |
| Medical Device Business Services, Inc. | 4 | $1,370 |
| Boston Scientific | 12 | $618 |
| Abbott | 5 | $309 |
| Amgen | 7 | $251 |
| Biosense Webster, Inc. | 2 | $241 |
| Kestra Medical Technology Services, Inc. | 2 | $127 |
| Atricure, Inc. | 1 | $103 |
| Novartis | 4 | $81 |
| Sanofi-aventis U.S. LLC | 2 | $50 |
| E.r. Squibb & Sons, L.L.C. | 3 | $44 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $44 |
| Merck | 2 | $36 |
| Cardiva Medical, Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $19 |
| Davol Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acticor 7 VR-T DX$4,228
- Edora 8 DR-T$4,051
- Rivacor 7 DR-T$3,894
- Solia$3,427
- BioMonitor$3,350
- Carto 3$1,611
- VersaCross Access Solution$1,508
- Micra$1,229
- Sentus$453
- Rhythmia Mapping System$300
- AMPLIA MRI QUAD CRT-D SURESCAN$216
- AMPLATZER$169
- Repatha$125
- Acticor$115
- Rivacor$115
- Edora$115
- Assure WCD$107
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$103
How this compares
$28,001 in reported general payments places this provider in the 90th percentile of 2,302 cardiovascular disease providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Colchicine | 17 | $1,170 |
| Pantoprazole Sodium | 16 | $135 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in East Syracuse
- Roger HajjarNew York$5.2M
- Szilard VorosStony Brook$3.7M
- Gregg StoneNew York$2M
- Augustin DelagoAlbany$1.8M
- Philippe GenereuxNew York$1.3M
- Adam RosenbluthNew York$1.1M
- Luigi di BiaseBronx$978K
- Vijay IyerAmherst$855K
- Megha PrasadNew York$813K
- Ronald DagostinoLake Success$782K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.